TherapeuticsMD
TXMD
TXMD
146 hedge funds and large institutions have $948M invested in TherapeuticsMD in 2016 Q4 according to their latest regulatory filings, with 29 funds opening new positions, 56 increasing their positions, 38 reducing their positions, and 20 closing their positions.
New
Increased
Maintained
Reduced
Closed
Holders
146
Holders Change
+9
Holders Change %
+6.57%
% of All Funds
3.66%
Holding in Top 10
–
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
–
New
29
Increased
56
Reduced
38
Closed
20
Calls
$3.79M
Puts
$4.12M
Net Calls
-$331K
Net Calls Change
-$4.81M
Top Buyers
| 1 |
Bank of New York Mellon
New York
|
+$31.9M |
| 2 |
GPP
Great Point Partners
Greenwich,
Connecticut
|
+$18.9M |
| 3 |
JPMorgan Chase & Co
New York
|
+$14.8M |
| 4 |
Millennium Management
New York
|
+$9.99M |
| 5 |
Franklin Resources
San Mateo,
California
|
+$5.66M |
Top Sellers
| 1 |
Wellington Management Group
Boston,
Massachusetts
|
-$45.1M |
| 2 |
Citadel Advisors
Miami,
Florida
|
-$6.43M |
| 3 |
D.E. Shaw & Co
New York
|
-$4.53M |
| 4 |
State of Wisconsin Investment Board
Madison,
Wisconsin
|
-$2.72M |
| 5 |
GTC
Ghost Tree Capital
New York
|
-$1.7M |
